Rating Change
Wolfe Research analysts downgraded Roivant Sciences Ltd. (NASDAQ:ROIV) from Outperform to Peer Perform on October 12, 2026.
downgradeNASDAQ:ROIV
Roivant Sciences Ltd. (ROIV) Downgraded to Peer Perform by Wolfe Research
Wolfe Research analysts downgraded Roivant Sciences Ltd. (NASDAQ:ROIV) from Outperform to Peer Perform on October 12, 2026.
At publication ·
What changed
Roivant Sciences Ltd. (NASDAQ:ROIV) · downgrade
- Firm
- Wolfe Research
- Rating
- Outperform to Peer Perform
- Price at event
- $34.59
- Market capitalization
- $14.8B
At a glance
Key takeaways
- Wolfe Research downgraded Roivant Sciences from Outperform to Peer Perform on October 12, 2026, which may influence institutional investor positions.
Market Context
Roivant Sciences Ltd. operates in the Healthcare sector. The stock currently trades at $34.59 with a market capitalization of $14.8B. The stock has gained 103.6% over the past 52 weeks.
Analyst downgrades can weigh on a stock in the short term as institutional investors who follow Wolfe Research's research adjust their positions. However, downgrades also sometimes create buying opportunities if the market overreacts to the rating change. The reasoning behind the downgrade matters more than the rating itself.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Roivant Sciences Ltd.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 12, 2026 | Wolfe Research | Peer Perform | N/A |
| Sep 17, 2026 | Stifel | Buy | N/A |
| Sep 09, 2026 | TD Cowen | Buy | N/A |
| Sep 09, 2026 | Guggenheim | Buy | N/A |
| Sep 08, 2026 | Jefferies | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ROIV Stock Page
Frequently Asked Questions
What does the Peer Perform rating mean for ROIV?
A rating of Peer Perform from Wolfe Research reflects the analyst's outlook on Roivant Sciences Ltd. (NASDAQ:ROIV). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ROIV forecast page.